. . . . . . . "[We identified the glycogen debranching enzyme AGL as a prognostic indicator of patient survival (P = .04) and as a novel regulator of bladder cancer anchorage-dependent (P < .001), anchorage-independent (mean \uFFFD standard deviation, 180 \uFFFD 23.1 colonies vs 20\uFFFD9.5 in control, P < .001), and xenograft growth (P < .001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:10:20+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .